A retrospective study of concurrent radiotherapy plus S-1 for treating advanced non-small cell lung cancer

We investigated the efficacy of concurrent radiotherapy plus S-1 (CRS) for treating unresectable stage III advanced non-small-cell lung cancer (ANSCLC). Seventy five ANSCLC patients were included in this retrospective study. Of those, 40 patients were assigned to an intervention group, and received...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Dejun, Feng, Jun-fei, Wang, Xue-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392540/
https://www.ncbi.nlm.nih.gov/pubmed/29851779
http://dx.doi.org/10.1097/MD.0000000000010740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392540/
https://www.ncbi.nlm.nih.gov/pubmed/29851779
http://dx.doi.org/10.1097/MD.0000000000010740

Ejemplares similares